Flagship Pioneering’s $50 M Warrant Deal Fuels Foghorn Therapeutics’ Oncology Growth
Flagship Pioneering’s $50 M warrant deal fuels Foghorn Therapeutics’ oncology pipeline, offering a low‑dilution future purchase price and extended runway to 2028.
3 minutes to read